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Objectives. The aim of this study was to assess whether dobut-
ine t ph I eeh raliography can identify viable myo-
cardium in patients with chronic myocardial infarction .
Background.
Experimental and clinical studies have shown
that dobutamine can recruit a contraction reserve in postischemic
viable but akinetic segments, indicating that dobulamninAnduced
functional recovery is a potential ultrasound worker of umyocar-
dial viability .
Methods. Forty patients underwent rest and dobutamnlne trans-
esophageal echocardiography (dobuta - e 5, 10 and 20 lkg
body weight per main) and fluorine-18 (F-18) lluorodeoxyglucose
positron emission tomography at rest. Three representative short-
aids tontograms and a transverse four-chamber-view were used
for wall motion and F-18 fluorodeoxyglucose-uplake analysis in
corresponding myocardial regions . A basally asynergic segment
was considered viable by transesophageal echocardiography If
dobuta ° e-induced systolic wall motion could be observed . Via-
bility by positron emission tomography was defined as F-18
fluorodeoayglucose uptake y50% of the maximal uptake in a
region with normal wall motion by left ventriculography .
In patients with chronic myocardial infarction and impaired
left ventricular function, the distinction between left ventric-
ular dysfunction due to irreversible myocardial damage
resulting in fibrotic scar formation and akinetic but viable
myocardium has important clinical implications (1) . Experi-
mental and clinical studies have suggested that postischemic
myocardial dysfunction can be transiently reversed by mod-
erate inotropic stimulation (2-5) and that this response may
be evaluated by echocardiographic detection of wall motion
or wall thickening (6) .
The detection of myocardial viability by means of echo-
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Results . Functional recovery within the infarct region was
found in 21 (53%) of 40 patients during dobutammine infusion .
Infarct region-related viability by F-18 fluorodeoxyglucose uptake
was diagnosed in 25 (63%) of 40 patients, yielding a diagnostic
agreement between both techniques in 90% of patients . In 210
(89%) of 235 alehretic segments at rest, date on myocardial
viability were concordant by the two techniques . The positive and
negative predictive accuracy of dobutamine transesophageal echo-
cardiography for viability defined by F-18 floor eoxyglucose
uptake was 81% and 97%, respectively . Such uptake was signif-
icantly different (p < 0 .001) between segments remaining akinetic
(mean t SD 45 t 9%) during dobutamine infusion and segments
with a dobutamine-induced contraction reserve (68 t 11%) .
Conclusions. butammmine transesophageal echocardiography
provides a promising low cost and widely available approach to
unmask myocardial viability in patients with chronic :myocardial
infarction, and results compare favorably with those of F-18
fluorodeoxyglucose positron emission tomography .
(J Am Cell Cordial 994,24:343-53)
cardiography is attractive from a clinical point of view,
because ultrasound imaging can be performed at low cost, is
widely available and is noninvasive and nonionizing . Tran-
sthoracic echocardiography has been used in conjunction
with dipyridamole (7) and low dose dobutamine (6,8,9) to
identify viable myocardium after acute myocardial infarc-
tion. However, in patients with a poor acoustic window the
transthoracic examination is not always feasible and endo-
cardial and epicardial borders are sometimes not completely
defined (10) . Superior image resolution can be obtained with
use of transesophageal echocardiography, which has been
reported to be a useful diagnostic technique in patients with
coronary artery disease (11-15) .
The present study was desigrcd to determine whether
low dose dobutamine transesophageal echocardiography
could detect residual viable myocardium in patients with
chronic myocardial infarction . Therefore, results of dobut-
amine transesophageal echocardiography were compared
with those of F-18 fluorodeoxyglucose positron emission
tomography, which served as the standard of reference for
0735 .10971941$7.00
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the differentiation of viable myocardial tissue and scar on the
basis of the cellular F-18 fluorodeoxyglucose uptake (16-18) .
Methods
Study patients
. We prospectively studied 42 consecutive
patients with angiographically documented coronary artery
disease (at least one major coronary vessel with >70%
diameter stenosis) and regional akinesia or dyskinesia by left
ventriculography (Table 1) between November 1992 and
October 1993 . Only patients with chronic myocardial infarc .
tion (a4 months since the ischemic event) were included in
this study. Patients were specifically excluded if they pre-
sented with diabetes, unstable angina, congestive heart
failure or a history of sustained ventricular tachycardia . Two
patients were excluded from the final evaluation . One patient
refused to swallow the transesophageal echocardiographic
probe and the other patient had diminished positron emis-
sion tomographic image quality due to latent diabetes melli-
tus. Of the remaining 40 patients (37 men, 3 women, age
range 37 to 72 years, mean age 59 ± 8 years), 22 patients
(55%) had received thrombolytic therapy at the time of acute
myocardial infarction (Table 1). The electrocardiographic
(ECG) site of myocardial infarction was anterior in 22
patients and inferior in 18 patients . This study was approved
by the Hospital Human Rights Committee (Institutional
Review Board) and informed consent was obtained from
every patient .
All patients underwent positron emission tomographic
and dobutamine transesophageal echocardiographic studies
within I week without intervening cardiac events . Beta-
adrenergic blocking agents were withdrawn 48 h before the
test. All patients received a long-acting nitrate (Isoket Re-
tard 120) before the echocardiographic and tomographic
studies .
C phy. Multiple views of each coronary
artery were obtained (DCI, Philips Einthoven) . Coronary
artery narrowing was assessed as percent diameter stenosis
with the use of electronic calipers . Regional left ventricular
wall motion was visually evaluated from the left ventriculo-
gram and graded as normokinetic, hypokinetic, akinetic or
dyskinetic. Only patients with regional akinesia or dyskine-
sia were included in this study .
Rest transes®phageal ec iographic studies. Trans-
esophageal echocardiography was performed after a 6-h fast
and application of lidocaine (Xylocaine) spray to the poste-
rior pharynx and administration of intravenous midazolam
(11) . Transesophageal imaging was accomplished by a com-
mercially available monoplane probe with a 5-MHz trans-
ducer attached to a Vingmed CFM750 (Sonotron) instru-
ment
. Rest and dobutamine image sequences were stored on
a VHS videotape for further evaluation . Acoustic power and
gray levels were appropriately adjusted to allow for optimal
real time imaging of the complete circumference of the left
ventricular endocardial border from base to apex.
By adjusting the depth of the probe and with various
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degrees of flexion of the tip, cross-sectional images were
obtained apical to the mitral leaflet level, at the papillary
muscle level and at the low papillary muscle-apical level
(Fig. 1). At each of these short-axis levels the transducer was
manipulated to obtain images perpendicular to the left ven-
tricular long axis showing a circular left ventricular cavity .
Additionally, a transverse four-chamber view was depicted
to visualize the more apical parts of the anterior wall (Fig . 1).
The position of the probe during the rest transesophageal
echocardiographic studies was documented by noting the
depth of the probe with respect to the bite guard for each of
the four anatomic levels .
Dobu ine Iran phageal echocardio phic studies .
After the acquisition of rest transesophageal echocardio-
grams, dobutamine (Dobutrex) was administered intrave-
nously under continuous 12-lead ECG monitoring and auto-
matic blood pressure recording every minute (BOSO
Oscillomat) . With a digital perfusion pump (Secura FT, B .
Braun Melsungen AG) an initial dose of 5 µg/kg body weight
per min was infused into a peripheral vein . After an equili-
bration period of 5 min, transesophageal echocardiographic
scans were repeated through the same sections by adjusting
the depth of the probe to the previously recorded values
from the rest transesophageal echocardiographic study . Fine
adjustments were made with regard to the size and shape of
the papillary muscles to provide an image as close as
possible to the baseline image . The dose of dobutamine was
then increased to 10 pg/kg per min and transesophageal
echocardiographic scans were repeated after another 5 min .
If a dobutamine-induced contraction reserve could be de-
tected during low dose dobutamine infusion or if significant
symptoms of arrhythmia or angina occurred, the protocol
was finished and the patient was observed with continuous
ECG monitoring for an additional 15 min . Otherwise, the
dobutamine infusion rate was increased to 20 ag/kg per min
and transesophageal echocardiography was repeated .
Image analysis. For each tomogram the image recorded
at the R wave of the ECG was considered to represent
end-diastole and end-systole was defined as the smallest
cross-sectional area. Using electronic tracing of the endo-
cardial border and software provided by the manufacturer
(Sonotron), the center of mass was determined for each
short-axis tomogram . A segmental pattern previously de-
scribed for the evaluation of magnetic resonance short-axis
and transverse tomograms (19,20) was used to divide each
short-axis tomogram into eight segments and each four-
chamber view into two apical segments by equally spaced
radii of 45° emanating from the center of mass (Fig . 1) . With
the segmental pattern in this position, parallel cine display of
digitized transesophageal echocardiographic scans was per-
formed for comparative wall motion analysis at rest and after
different doses of dobutamine . Segmental wall motion was
graded as hypokinetic if wall motion and systolic wall
thickening were reduced but not absent . A segment graded
as akinetic showed neither wall motion nor wall thickening,
and a segment considered dyskinetic had systolic outward
*Patient (Pt) with diminished image quality by fluorine-18 fluorodeoxyglucose (FM positron emission tomography (PET) due to latent diabetes
. iPatient who
refused to swallow the transesophageal probe . Discrepant findings of dobutamine transesophageal echocardiography (TEE) and positron emission tomography
are indicated in boldface type ; arteries with total occlusion are indicated in
liahrs . CC
= collateral circulation
; ECG = electrocardiographic ; F = female
;
LAD = left anterior descending coronary artery ; LCx = left circumflex coronary artery ; M = male
; RCA = right coronary artery ; - = no ; + = yes
.
movement of the endocardial border and showed no systolic graphic and positron emission tomcgraphic findings
. Inter-
wall thickening but sometimes systolic wall thinning
. All observer agreement was 93% (966 of 1,040 segments) with a
tomograms were analyzed on a segmental basis by two maximal difference of I grade between two wall motion
observers who had no knowledge of the left ventriculo-
	
readings . Fifty-one (4 .9%) of 1,040 segments were graded
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Table t . Clinical, Left €1entricttlographic, Coronary Angiographic, Dobutamine Transesophageal Echocardiographie and s vsitror .
Emission Tomographic Findings
Patient Data
Coronary Angtography
ECG Q
Waves
Infarct Region
Dobutamine TEE
Residual Viability
(dobutamine-
induced
contraction
reserve)
FDG PET
Residual Viability
(FDG uptake
?50%)
Left Ventricular Wall
Metion Abnormalities
Stenoses
(%o diameter
reduction)
CC
Pt
No.
PI Age
(yr)/
Gender
Infarct
Age Thromboly€ic
(MO) Therapy LAD LCx RCA
I 71/M 36 Anteroseptal dyskinesia 100 0 0
-
V3-V6 Complete Scar Complete scar
2 61/M 4 Anterior akinesia 90 0 0
-
V3-V4 Complete scar Complete scar
3 39/M 5 + Posterior akincsin 50 100 80 II,III,aVF Complete scar Complete scar
4 571M 8 Posterior akinesia 0 60 70
-
11,II1,aVF Complete scar Complete scar
5 591M 120 + Anteroseptal dyskinesia 90 0 100
-
V3-V6 Complete scar Residual viability
6 72/M 109 + Anterior akinesia 80 Go 00 V,-V4 Complete scar Complete scar
7 55/F 118
-
Anterior akinesia 100 0 0
- 1'2-V4 Complete sear Complete scar
8 651M 180
-
Anterior dyskinesia 100 50 100 LCx V,-V6 Residual viability Residual viability
9 611M 12
-
Anterior akinesia 100 80 0 V,-VS Residual viability Residual viability
10 691M 6
+ Anterolateral akinesia 0 95 0
-
No Q waves Residual viability Residual viability
I I 541M 13 Posterior akinesia 70 50 95
-
V,-V4 Residual viability Residual viability
12 56'M 8
-
Anterior akinesia 100 100 0 RCA V,-V5 Residual viability Residual viability
13 541M 36 + Anterior dyskinesia 100 70 0
- V'-V' Complete scar Complete scar
14 591M 14 + Anterior dyskinesia 90 0 0
- V,-Vs Complete scar Complete scar
15 691M 12 + Anterior akinesia 95 0 0 V2-V4 Complete scar Complete scar
16 501F 10 Posterior akinesia 70 0 100
V,-V6 Residual viability Residual viability
17 661h1 14
+ Posterior dyskinesia 0 100 100 LAD II,I11,aVF Complete scar Complete scar
I8 581M 4 + Anterior akinesia 100 0 95 LCx No Q waves Residual viability Residual viability
19 581M 4 + Posterior akinesia 0 0 90
- No Q waves Residual viability Residual viability
20 371M 96 Anterior akinesia 90 0 0
- V2-V5 Residual viability Residual viability
21 63/M 84 Anterior akinesia 95 50 100 LCx
V2-V4 Residual viability Residual viability
22 591M 36 Posterior dyskinesia
50 100 100 LAD II,III,aVF Complete scar Complete scar
23 66/M 144 Anterior akinesia
100 90 50 RCA No Q waves Residual viability Residual viability
24 621M 11 + Posterior dyskinesia 95 50 100
-
II,III,aVF Complete scar Complete scar
25 62/M 5 + Posterior akinesia 50 0 80
- No Q waves Residual viability Residual viability
26 67/M 10
+ Posterior akinesia 0 0 90
- No Q waves Residual viability Residual viability
27 69/M 16
+ Posterior akinesia 75 50 100 LCx II,IIL,aVF
Residual viability Residual viability
28 53/M 6
-
Posterior dyskinesia 70 50 100 LC'x Il,1ILaVF Complete scar
Complete scar
29 63/M 11 + Posterior akinesia 70 n 100
II,IIL,aVF Complete scar ResIdual viability
30 53/M 84 Posterior akinesia 95 50
95 LCx No Q waves Residual viability Residual viability
31 531M 12 Posterior akinesia
50 90 100 -- IMH,aVF Residual viability Residual viability
32 57/M 4
+ Anterior akinesia 90 0 0
-
No Q waves Complete scar Complete scar
33 651M 96 Anterior akinesia
100 0 70
-
V2-V5 Complete scar Residual viability
34 461M 7 + Anterior akinesia 95 0 0
- No Q waves Residual viability Residual viability
35 67/M 5 + Posterior akinesia
0 100 109 LAD II,III,aVF Residual viability
Residual viability
36 52/M 6
-
Posterior akinesia
0 80 95 - I1,III,aVF Complete scar Complete scar
37 61/F 7 + Posterior akinesia
0 95 0
- No Q waves Residual viability Residual viability
38 571M 8 + Anterior akinesia
70 80 0
-
No Q waves Residual viability Residual viability
39 61/M 112 + Anterior akinesia
100 100 50 RCA V2 -V5 Residual viability
Residual viability
40 601M 120
-
Anterior akinesia 100 50 7D
- V2-V4 Complete scar Residual viability
41* 43/M I I Anterior dyskinesia
100 0 0
- Vz V5 Complete scar
-
42t 561F 13 + Posterior akinesia
0 0 90
-
11,111,aVF
-
Residual viability
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1 .Figure Segmental evaluation pattern for corresponding trans.
esophageal echocardiographic and fluorine-18 fluorodeoxyglucose
positron emission tomography . Diagrams illustrate the position of
two-dimensional transesophageal echocardiographic short-axis
views and a four-chamber view selected for a segmental comparison
with corresponding positron emission tomograms . The position of
the transesophageal echocardiographic probe (P) was adjusted to
produce short-axis views perpendicular to the long axis of the heart .
The depth of the probe was noted with respect to the bite guard at
each anatomic level to allow for optimal reproducibility of the same
view during different levels of dobutamine stress . Each short-axis
tomogram was divided into eight segments (AW = anterior wall ;
LW = lateral wall; PW = posterior wall ; SW = septal wall) by
equally spaced radii emanating from the endocardial center of mass
(M) beginning from the junction (1) of the intraventricular septum
and the right ventricular (RV) wall . Four-chamber views demon-
strating the apical aspect of the anterior wall were divided into two
segments (AP) . LV ° left ventricle; RV = right ventricle .
differently in sequential readings by the same observer . The
maximal difference between two readings was I grade .
These findings are in agreement with those of a previously
published study (21) . When there was a disagreement in
segmental gradings, a third observer reviewed the study, and
the subsequent .itajority judgment was binding. Akinetic and
dyskinetic segments were graded viable if segmental wall
motion improved to hypokinesia .
18 xyglucose positron emission tomogra-
. Positron emission tomography was performed by using
a whole body scanner (Siemens CTI ECAT EXACT 921)
with an axial field of view of 16.2 cm and equipped with
germanium-68 gallium-68 retractable line sources for trans-
mission scans. To improve myocardial glucose uptake, each
patient received a solution of glucose, 50 g, 1 h before the
administration of F-18 fluorodeoxyglucose. Images were
corrected for attenuation by using coefficients measured by
a transmission scan of 30 min duration . Emission scans
(6 x 5 min) were started 30 min after injection of F-18
fluorodeoxyglucose, 370 MBq (10 mCi). The transaxial res-
olution was 6 mm full width at half maximum (22).
Image analysis . Quantitative assessment of segmental
F-18 fluorodeoxyglucose uptake was carried out on three
short-axis positron emission tomograms that corresponded
to transesophageal echocardiographic sections . For the four-
chamber view a transverse positron emission tomogram
intersecting the mitral valve plane and the apex was evalu-
ated. For the selected short-axis tomograms (slice thickness
8 mm), a polar map was generated by means of a SUN
workstation . The polar map was divided into eight segments
using the same segmental pattern as described for the
transesophageal echocardiographic study (Fig . 1) . For trans-
verse tomogratns, two regions of interest (Fig . 1) corre-
sponding to the segmental transesophageal echocardio-
graphic evaluation were created encompassing two apical
segments. For each segment the mean F-18 fluorodeoxyglu-
cose uptake was calculated in percent of the segment with
the maximal F-18 fluorodeoxyglucose uptake. This segment
was required I) to be perfused by a coronary artery with
DSO% diameter stenosis, and 2) to have normal wall motion
by left ventriculography in order to avoid misinterpretation
of F-18 fluorodeoxyglucose uptake, which could occur if the
maximal F-18 fluorodeoxyglucose uptake happened to be in
a viable but ischemic segment with severely reduced perfu-
sion at rest (23) . Positron emission tomographic segments
were defined as viable if the mean segmental F-18 fluoro-
deoxyglucose uptake was X50% of the maximal F-18 fluo-
rodeoxyglucose uptake .
Statistical analysis. Values were expressed as mean value
* I SD. Serial changes in heart rate, systolic blow pressure
and rate-pressure product during dobutamine infusion were
analyzed by Student t test . Differences between dobutamine
transesophageal echocardiography and positron emission
tomography with respect to the identification of viable
myocardium in different patient groups were assessed by a
chi-square test. Differences between segmental F-1S fluoro-
deoxyglucose uptake for segments with different transesoph-
ageal echocardiographic gradings at rest and during dobut-
amine infusion were assessed by analysis of variance .
Sensitivity, specificity and predictive accuracy of dobut-
amine transesophageal echocardiography were calculated by
applying standard formulas . The null hypothesis was re-
jected at the 95% confidence level, considering a p value <
0.05 as significant .
Results
Clinical characteristics. Of 40 patients with chronic myo-
cardial infarction (mean infarct age 36 ± 47 months, range 4
to 180) with completed dobutamine transesophageal
echocardiographic and positron emission tomographic stud-
ies, I1 patients had a non-Q wave infarction (mean peak
creatine kinase 1,170 ± 716 U/liter) and 29 patients had a Q
wave infarction (mean peak creatine kinase 2,970 ± 1,780
U/leter) . A totally occluded infarct-related vessel was found
in 72% (21 of 29) of patients with Q waves and in 18% (2 of
11) of patients with a non-Q wave infarction . Thirteen
JACC Vol. 24, No. 2
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Table 2. H emadynamic Variables at Rest and During Different Levels of Dobutamine
Infusion in Relation to the Dobulamine-induced Contraction Reserve in Basally Akinetic or
Dyskinetic Segments
patients had one-vessel, 14 patients had two-vessel and 13
patients had three-vessel coronary artery disease .
Malamine tranmmophagpal 4whetanCography. The low
dose dobutamine transesophageal echocardiographic stress
protocol (dobutamine, 5 and 10 pg/kg per min) was success-
fully completed in all patients, The higher dose dobutamine
infusion protocol (20 µg/kg per min) had to be performed in
13 patients. At the 10-,ug/kg per min dobutamine infusion
level, three patients developed frequent ventricular prema-
ture beats and two patients had mild chest pain That was
quickly relieved by sublingual nitroglycerin . Other side
effects experienced by patients included palpitation (15%)
and tingling or flushing sensations (12%) . Hernodynamic
changes between rest and dobutamine infusion levels are
shown in Table 2 .
Viable myocardium in at least one segment of a basally
akinetic region was found by dobutamine transesophagcal
echocardiography in 21 (53%) of 40 patients. Table I shows
the clinical and angiographic characteristics of patients with
and without a dobutamine-induced contraction reserve .
There were no significant differences between these patient
groups with respect to age, site of infarction, number of
diseased vessels or number of patients with totally occluded
vessels. However, there were significantly more patients
with Q wave (17 of 29 [73%]) than with non-Q wave (1/11
[9%]) infarction who did not respond to dobutamine infu-
sion.
On a segmental basis, a total of 1,040 transesophageal
echocardiographic segments were evaluated at rest and during
dobutamine infusion . At rest, there were 805 segments with
normal or hypokinetic wall motion ; of the remaining 235
segments, 214 were graded AM& and 21 were graded dysti
netic .
A dobutamine-induced contraction reserve could be de-
tected in 64 of the 235 akinetic or dyskinetic segments by
using the 5-jug regimen (64 1279ol of 235) (Table 3A) and in 28
additional segments (92 [39%] of 235) (Table 3D) by using the
10-jAgg dobutamine dose . When segments were analyzed with
respect to their initial contraction pattern (214 akinetic and
21 dyskinefic), a dobutamine-induced contraction reserve
BAER ET AL .
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Viable
Sear
Total
Viable
Scar
Total
*Significantly (p < 0 .0001) greater number of segments with dobutamine-induced contraction reserve fulfilling
fluorine-18 f1ticrodeoxyglucose positron emission tomographic criteria of myocardial viability compared with that
obtained with the lower (5 pglkg per min) dobummine dose . BP = blood pressure .
was present in only 2 (9%) of 21 dyskinetic segments but in
90 ONO of 214 akinetic segments . Segments graded akinetic
and dyskinetic by rest transesophageal echocardiography
also had a significantly (p < 0.001) different F-18 fluoro-
deoxyglucose uptake (akinetic segments 55 ± 14%, dyski-
netic segments 40 ± J I %) . The higher dobutamine infusion
rate (20 µg/kg per min) did not improve the results with
respect to the induction of a contraction reserve in basally
akinetic or dyskinetic segments but led to a deterioration of
wall motion in 30 normal or hypokinetic segments .
Fluorine-18 fluoredeoxyglucose positron emission tomogra .
phy. Positron emission tomography revealed the presence
of viable myocardium (i .e., a regional F-18 fluorodeoxyglu-
cose uptake ?50% of the maximal F-18 fluorodeoxyglucose
uptake) in the akinetic or dyskinetic infarct zone assessed by
rest transesophageal echocardiography in 25 (63%) of 40
patients (Fig . 2 and 3) . Twenty-one (84%) of these patients
demonstrated a dobutamine-induced contraction reserve in
at least one segment graded akinetic or dyskinetic at rest,
whereas four patients with persisting viable myocardium by
positron emission tomography did not show a contraction
reserve during dobutamine transesophageal echocardiogra-
phy . These four patients had a previous Q wave infarction
Table 3 . Comparison of Dobutamine Transesophageal
Echocardiographic and Positron Emission Tomographic Grades
for 235 Akinetic Segments
Dobutamine TEE
FDG-PET
	
Viable Scar
A. 5-W)kg per min Dobutamine, Infusion Rate
62
2
64
B. I0-pZ/kg per min Dobutamine Infusion Rate
88
4
92
Abbreviations as in Table 1 .
47 109
124 126
171 235
21
122
143
347
Total
109
126
235
Du6ulanune Dose (pg/kg per min)
Rest 5 10 20
Heart rate (beatshnin) 74±14 79 ± Is 80 ;t 21 122 ± 20
Systolic BP (men Hg) 112 ± 14 118 15 125 ± 21 135 ± 28
Rate-pressure product (mm Homin) 8,300 ± 2,200 9,300 2,300 11,000 ± 2,500 16,500 ± 3,200
Dobutarnino-induced contraction n = 235 64/235 QIB* 92/235
reserve in basally akiactic or
dysLinefic segments (27%) (39%)(39%)
348:
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and at least one totally occluded major coronary artery . No
patient with a dobutamine-induced contraction reserve was
graded as having complete scar by positron emission tomog-
raphy (Table 1) . Consequently, both techniques agreed in 36
(90%) of the 40 patients.
On a segmental basis 901 segments were graded as viable
and 139 segments were graded as scar by positron emission
to y. Of the latter 139 segments, 13 (9%) were hypok-
inetic by rest trattsesop al echocardiography ; most of these
segments (75%) were located in the border zone of the infarct
and had a F-18 fluorodeoxyglucose uptake close to the 50%
threshold value (44 t 5%) .
C ~d
y and F-18 tomog.
raphy. Overall correspondence between the segmental
gradings of transesophageal echocardiography and positron
emission tomography was 94% (974 of 1,040 segments) at the
JACC Vol . 24, No . 2
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Figure 2. Dobutamine transesoph-
ageal echocardiograms (top) and
positron emission (bottom) midven-
tricular short-axis tomograrn from a
patient with anterior myocardial in-
farction and 100% stenosis of the left
anterior descending and 80% stenosis
of the left circumflex coronary arter-
ies. The end-diastolic phase shows
reduced wall thickness ( l arrows)
a rest (upper left panel) and during
dobutamine infusion (lower left panel)
in the anterior and septal region . At
end-systole the rest contraction pat-
ted (upper right panel) demonstrates
normal wall thickening of the poste-
rior and lateral walls but lack of wall
thickening in the anterior (arrow) and
septa) (arrow) region . During dobut-
amine infusion (lower right l),
systolic wall thickening of the ante-
rior wall (triangle) could be observed,
but the septa) region remains akinetic
(am); this region corresponds to the
septal region with markedly reduced
fluorine-1B fluorodeoxyglucose uptake
( w) in the short-axis positron emis-
sion tomogram .
5- and 96% (1,002 of 1,040 segments) at the 10-pglkg per min
dobu?omine infusion stage . In 235 basally akinetic or dyski-
netia: segments, data on myocardial viability were concor-
dant by the two techniques in 210 (d9%) of segments, with
37% identified as viable and 52% identified as scar by both
dobutamine transesophageal echocardiography and positron
emission tomography .
In particular, of the 235 segments with akinesia or dyski-
nesia by rest transesophageal echocardiography, 109 (46%)
were graded viable by positron emission tomography . Dur-
ing low dose dobutamine infusion (5 pglkg per min), 62 of
109 viable segments by positron emission tomography dem-
onstrated a dobutamine-induced contraction reserve (Table
3A), that is, a positive predictive accuracy of 57% for
dobutamine transesophageal echocardiography-obtained
contraction reserve compared to positron emission tomog-
raphy. With the higher dobutamine dose (10 pg/kg per min)
JACC Vol. 24, No . 2
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Figure 3. Dabutamine tratisesopha-
geal echocardiograms (top) and
positron emission (bottom) basal
short-axis tomogram from a patient
with anterior myocardial infarction
and 90% stenosis of the left anterior
descending coronary artery . At rest
(upper left panel) the end-diastolic
thickness of the anterior wall ap-
pears slightly reduced (arrows), and
the same region shows lack of wall
thickening (arrow) at end-systole
(upper right panel) . During dobw-
amine infusion, significant systolic
wall thickening (lower right panel)
of the basally akinetic anterior wall
(arrow) could be induced, a finding
in agreement with the homoge-
neous fluorine-18 fluorodeoxyglu-
case uptake of the corresponding
positron emission short-axis tome-
gram .
88 of 109 viable positron emission tomographic segments
developed a dobutamine-induced contraction reserve (Table
3B), resulting in a positive predictive accuracy of 81% for
transesophageal echocardiography .
Fluorine-18 fluorodeoxyglucose-uptake in transesophage-
al echocardiographic segments with akinesia or dyskinesia at
rest but a dobutamine-induced contraction reserve was
significantly (p < 0 .001) higher (68 :: 11l) than in segments
remaining akinetic during dobutarnine infusion (45 ± 9%)
(Fig. 4). A segmental discordance by positron emission
tomographic and dobutamine transesophageal echocardio-
graphic viability criteria was found in 25 segments (Table 3B,
Fig. 4), that is, 23% of all basally akinetic segments graded
viable by positron emission tomography . Four segments
with dobutamine-induced contraction reserve were graded
as scar by positron emission tomography, yielding a negative
predictive accuracy of 97% . The F-18 fluorodeoxyglucose
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uptake in these segments was close to the threshold value
(46 ± 3 1YR
Discussion
Assessment of residual myocardial viability in the setting
of chronic myocardial infarction is crucial for clinical deci-
sions with respect to further treatment . Previous studies
(6,8,9) have shown that low dose dobutamine stress echo-
cardiography can identify contractile reserve in patients
shortly after acute myocardial infarction . The present study
extends these observations to patients with chronic myocar-
dial infarctionn using a multistage low dose dobutamine
transesophageal echocardiographic protocol . The transesoph-
ageal approach was chosen because of its superior image
quality, allowing a better definition of endocardial and
epicardial borders, which facilitates the qualitative evalua-
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Lion of wall thickening even in the presence of a discrete
dobutamine-i1iduced contraction reserve (15). Moreover, in
patients with a poor acoustic window due to obesity, chronic
obstructive pulmonary disease and chest deformities, which
potentially lead to inadequate image quality, dobutamine
transesophageal echocardiography is a valuable alternative
to the transthoracic approach for the assessment of residual
myocardial viability (10) . This is also reflected by the high
degree of correspondence between segmental wall motion
gradings by dobutamine transesophageal echocardiography
and quantitative assessment of F-18 fluorodeoxyglucose
uptake. However, the good overall correspondence (96%)
between both imaging techniques partly relates to the large
number of segments (805 [77%) of 1,040) with normal wall
motion . Exclusive evaluation of segments with preexisting
wall motion abnormalities (235 [23%) of 1,040) even using
the optimal dobutamine infusion level (10 pgtkg per min)
yielded a lower segmental correspondence (89°10) with
positron emission tomographic findings .
In the present study, functional recovery during low dose
dobutamine infusion was observed in >50% of patients with
chronic myocardial infarction and severe wall motion abnor-
malities by left ventriculography . Comparison of dobut-
amine transesophageal echocardiography and positron emis-
sion tomography yielded an agreement with respect to the
identification of residual myocardial viability in the infarct
zone in 90% of patients. Segmental comparison of both
techniques showed an 81% positive predictive accuracy of a
dobutamine-induced contraction reserve for viability as de-
fined by positron emission tomography . A dobutamine infu-
sion dose of 10 pg/kg per min yielded the best identification
of residual myocardial viability by transesophageal echocar-
diography as compared with positron emission tomography .
induction of contractile reserve in chronic
iuforcis. A situation of chronic contractile dys-
function in hypoperfused but viable myocardium that nor-
maiizes on reperfusion has been defined as "hibernation"
skinatle
moms
without connasxuon
ro rva (no143)
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Figure 4. Segmental fluorine-18 (F-lb) fluorodeoxyglucose
uptake with respect to transesophageal echocardiographic
wall motion grades . Comparison of mean segmental F-18
fluorodeoxyglucose uptake with respect io basally viable
segments (normal and hypokinetic wall motion at rest, open
bars) and basally akinetic or dyskinetic segments, which
were subdivided into those with dobutamine-induced con-
traction reserve (soled ) and those remaining akinetic
(crosshatched bars) .
(24) . In contrast to experimental models describing the
short-term effects of myocardial ischemia on left ventricular
function and the susceptibility of dysfunctional myocardium
to inotropic stimulation (25,26), hibernation is a clinically
defined condition . Animal models that describe the effects of
a prolonged reduction of myocardial blood flow for more
than a few hours are not available (27) . However, the
improvement of left ventricular wall motion in regions of
hibernating myocardium during inotropic stimulation has
been shown to be a predictor of improved left ventricular
function after revascularization (28-30) . In particular, pa-
tients with depressed left ventricular function who demon-
strate significant improvement of ejection fraction during
inotropic stimulation have improved left ventricular function
and a better long-term survival after coronary revascular-
ization (28). This finding is in agreement with a recently
published echocardiographic study (10) reporting that a
dobutamine-induced contraction reserve in chronic infarcts
is a good predictor of left ventricular improvement after
revascularization.
Iobutamine transesophageal echocardiography. Previous
studies (14,15) have demonstrated that transesophageal
echocardiography is a sensitive method for detecting isch-
emia-induced segmental wall motion abnormalities with a
better sensitivity and specificity for identifying significant
coronary artery disease than those of the transthoracic
approach. The high signal to noise ratio and the lack of
interference by the respiratory cycle are the major advan-
tages of this technique . Thus, the success rate of obtaining
two-dimensional echocardiograms of diagnostic quality from
the transesophageal approach was very high in the present
study, as was that in a previously reported study (13) using
transesophageal echocardiography and simultaneous atrial
pacing . The entire endocardial and epicardial contours could
be visualized in most patients . Therefore, wall motion anal-
ysis could be based not only on the impression of III!,. inward
motion of the endocardial border toward the center of the
JACC Vol
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left ventricle, but also on the observation of the degree of
myocardial thickening . Additional assessment of myocardial
thickening seems to be particularly important in the setting
of low dose dobutamine infusion, which sometimes results in
only subtle differences in the left ventricular contraction
pattern. However, biplane and multiplane transesophageal
transducers may further increase the diagnostic sensitivity of
this new method in the assessment of myocardial viability
(11,31).
Fluorine-18 fluorodeoxyglucose positron emission tomoc
graphic imaging . Positron emission tomography is con-
sidered to be the reference method for the noninvasive
identification of viable myocardium in patients with a com-
promised left ventricle . The preserved glycolytic activity as
estimated by regional F-18 fluorodeoxyglucose uptake in
myocardial regions with impaired function has been reported
to be accurate for the differentiation of viable myocardial
tissue from sear (16-181231 . Segments with a i-50% F-18
fluorodeoxyglucose uptake relative to the maximal F-18
fluorodeoxyglucose uptake in a myocardial region with nor-
mal wall motion were defined viable by positron emission
tomography. This corresponds to the common positron
emission tomographic criterion for viability defined as rela-
tive uptake of w50% F-18 fluorodeoxyglucose in an area with
reduced blood flow as measured by nitrogen-13 ammonia or
oxygen-15 water or normal myocardial function (34) . To
overcome the problem of falsely relating regional F-18
fluorodeoxyglucose uptake to a maximal uptake occurring in
an ischemic segment (a positron emission tomographic flow
tracer was not available), the reference segment was re-
quired to be perfused by a vessel with normal perfusion at
rest (:s50% diameter stenosis) and normal wall motion by
left ventriculography (35) .
Comparison with previous studies. Previous studies have
shown that low dose dobutamine transthoracic echocardiog-
raphy can identify contractile reserve in patients with acute
myocardial infarction . Pierardd et al . (6) reported concordant
findings of echocardiographic wall motion analysis and
positron emission tomography in 79% of infarctcd segments
with 48% gradings of viability and 31% gradings of scar .
Among the 16 segments (21%) with discordant results by the
two techniques, 7 were considered to show viability by
echocardiography but scar by positron emission tomogra-
phy; conversely, 9 were considered to show viability by
positron emission tomography but scar by echocardiogra-
phy. Comparison of dobutamine transesophageal echocardi-
ography and positron emission tomography in the present
study yielded corresponding gradings in 89% of basally
akinetic or dyskinctic segments with a mismatch in 25
segments (11%) . Among these segments, 21 were graded as
viable by positron emission tomography but as scar by
dobutamine transesophageal echocardiography, and only 4
segments were graded as viable by dobutamine transesoph-
ageal echocardiography but as scar by positron emission
tomography. Thus, metabolic activity by positron emission
tomography does not always correspond to reversible dys-
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function . This finding is in agreement with data from animal
models (36) demonstrating that myocardial regions became
incapable of functioning if a threshold percentage of trans-
mural irreversible damage was exceeded although some
viable myocardium remained . Therefore, positron emission
tomography may detect metabolic activity in regions with
severely impaired left ventricular function in which only
small remnants of viable myocardium have survived . These
particular regions may not be able to produce a detectable
amount of contraction under dobutamine stimulation or after
revascularization (16,37) .
However, other factors may have contributed to the ob-
served segmental discordance between the two techniques
. 1)
There may have been a slight discrepancy between the short-
axis tomograms evaluated by each technique. 2) The use of
wall motion analysis instead of quantitative assessment of
segmental wall thickening may have resulted in underestima-
tion of the subtle increases of dobutamine-induced contractil-
ity . 3) Effects of cardiac translation or tethering could not be
completely compensated for.
Recently Smart et al . (9) reported that dobutamine-
responsive wall motion after thrombolytic therapy was very
specific for reversible dysfunction after revascularization
(>9O%) and yielded a sensitivity of 86% with the use of low
dose dobutamine. This finding is in agreement with the
present study, which demonstrated the best correspondence
(89%) between positron emission tomographic and dobut-
amine transesophageal echocardiographic gradings in ba-
sally akinctic segments with a low dose infusion rate of
10 pg/kg per min. A further increase of the infusion rate
(20 Aglkg per min) did not lead to an increased number of
segments with an inotropic contraction reserve, but deteri-
oration of wall motion due to dobutarriine-induced ischemia
could be observed in 30% of patients .
Only one transthoracic echocardiography study has ad-
dressed the diagnosis of residual viability by a dobutamine
contraction reserve in chronic myocardial infarction . Cigar-
roa et al. (10) reported that 24 (49%) of 49 patients with
chronic myocardial infarction developed a dobutamine-
induced contraction reserve . Among 25 patients who under-
went revascularization, 9 (85%) of I I had improved systolic
wall thickening after revascularization and 12 (86%) of 14
patients without a dobutamine-induced contraction reserve
showed no improvement . Although results after revascular-
ization are not available in our patients, in the present study
transesophageal echocardiography detected viable myocar-
dium in a proportion of patients similar to that detected with
the reference technique, positron emission tomography .
Study limitations. Several limitations of the present study
merit comment . 1) A disadvantage of transesophageal echo-
cardiography is that it requires oral passage of a large probe
with all the precautions and complications inherent to this
procedure in awake patients . However, success rate with
respect to image quality was 100%, whereas the trans-
thoracic approach results in >1096 patient dropout because
of inadequate image quality (10) . 2) Even though the com-
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bined evaluation of the short-axis plane and additional
depiction of a four-chamber view allows for visualization of
most of the myocardium supplied by the main coronary
arteries, in some patients the apex remains a relatively
obscured area (12,38) . The use of multiplane transesopha-
geal" transducers may further increase the diagnostic accu-
racy of transesophageal echocardiography in this region
(11,31). 3) Qualitative analysis of regional myocardial func-
tion requires experienced observers and may be aided by
digital processing techniques. However, measurement of
segmental systolic wall thickening is time-consuming and
still results in endocardial and epicardial signal dropouts
because image quality appears markedly reduced after digi-
tization of end-diastolic and end-systolic still frames with
commercially available software . Therefore, qualitative im-
age analysis of both wall thickening and wall motion remains
the current standard with minimal interobserver variability
(39,40) .
Co Low dose dobutamine transesophageal echo-
cardiography is a safe, feasible and, in comparison with
positron emission tomography, cost-effective and widely avail-
able method providing high quality images for identifying
residual myocardial viability in patients with chronic myocar-
dial infarction. The clinical impact of low dose dobutamine
transesophageal echocardiography cannot be ascertained from
this study . We therefore recommend further comparative stud-
ies of dobutamine transesophageal echocardiography and F-18
fluorodeoxyglucose positron emission tomography in a larger
cohort of patients with results after revascularization of aki-
netic or dyskinetic myocardium .
We thank Erland Erdmann, MD and Klaus Wienhard, MD for their helpful
advice . We are grateful to Wolf-Dieter Hei$, MD, Max-Planck Institut for
Neurologische Forschung, for providing the facilities for the positron emis-
sion tomographic studies .
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